Dubé, Karine
Kanazawa, John
Patel, Hursch
Louella, Michael
Sylla, Laurie
Sheehy, Jeff
Dee, Lynda
Taylor, Jeff
Adair, Jen
Anthony-Gonda, Kim
Dropulić, Boro
Sauceda, John A.
Peluso, Michael J.
Deeks, Steven G.
Simoni, Jane
Funding for this research was provided by:
National Institute of Mental Health (R21MH118120)
Article History
Received: 15 April 2021
Accepted: 4 April 2022
First Online: 9 April 2022
Declarations
:
: The Institutional Review Board of the University of North Carolina at Chapel Hill approved this empirical research ethics study (study #: 19-0522). All interview participants included in this study provided informed consent. All methods were carried out in the accordance with relevant guidelines and regulations.
: All participants provided informed consent to publish de-identified data.
: K.D. provides socio-behavioral and ethics support to the California Institute of Regenerative Medicine (CIRM)/City of Hope, the defeatHIV Collaboratory (UM1 AI126623) and the BEAT-HIV Collaboratory (UM1AI126620). K.D. has ongoing socio-behavioral sciences and ethics collaborations with the Delaney AIDS Research Enterprise (UM1AI126611). S.G.D. reports Grants and/or personal fees from Gilead Sciences, Merck & Co, and ViiV, consulting fees from AbbVie, and serves on the Scientific Advisory Board of Enochian BioSciences. S.D.G. also has a Grant from CIRM to perform a CAR-T cell study and assists a non-profit (Caring Cross) focused on addressing global CGT equity. Remaining authors have no competing interest.